AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?
- PMID: 17656146
- PMCID: PMC2041795
- DOI: 10.1016/j.cytogfr.2007.06.005
AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?
Abstract
Interferon alfa (IFNalpha) was one of the first agents to be used therapeutically in AIDS-associated Kaposi's sarcoma (KS) more than 25 years ago, and induces tumor regression in a subset of patients. Although much has been learned about the clinical role of IFNalpha in KS treatment, little is currently known about the mechanism(s) by which IFNalpha causes KS regression. This is despite a growing understanding of both KS pathogenesis and relevant IFNalpha activities. To a large extent other agents have supplanted IFNalpha as treatments for KS, but there may still remain a therapeutic role for IFNalpha, possibly in combination with other agents targeting angiogenesis and/or HHV-8-encoded human gene homologs that encode proteins involved in cell cycle regulation and signaling.
Similar articles
-
Biology and therapy of epidemic Kaposi's sarcoma.Cancer. 1987 Feb 1;59(3 Suppl):633-7. doi: 10.1002/1097-0142(19870201)59:3+<633::aid-cncr2820591311>3.0.co;2-i. Cancer. 1987. PMID: 10822462 Review.
-
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.Eur J Med Res. 1999 Dec 16;4(12):507-13. Eur J Med Res. 1999. PMID: 10611054 Clinical Trial.
-
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.Eur J Dermatol. 2007 Nov-Dec;17(6):539-40. doi: 10.1684/ejd.2007.0274. Epub 2007 Oct 19. Eur J Dermatol. 2007. PMID: 17951139 No abstract available.
-
Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.Cancer Invest. 2005;23(8):653-9. doi: 10.1080/07357900500358259. Cancer Invest. 2005. PMID: 16377582
-
Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma.J Interferon Cytokine Res. 1998 Apr;18(4):209-14. doi: 10.1089/jir.1998.18.209. J Interferon Cytokine Res. 1998. PMID: 9568721 Review.
Cited by
-
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.J Acquir Immune Defic Syndr. 2023 Oct 1;94(2):165-173. doi: 10.1097/QAI.0000000000003236. J Acquir Immune Defic Syndr. 2023. PMID: 37368929 Free PMC article.
-
The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma.AIDS Res Ther. 2008 Jan 29;5:2. doi: 10.1186/1742-6405-5-2. AIDS Res Ther. 2008. PMID: 18226270 Free PMC article.
-
Aggressive classical Kaposi's sarcoma mimicking malignant lymphoma.Pathol Oncol Res. 2012 Oct;18(4):1067-9. doi: 10.1007/s12253-012-9545-5. Epub 2012 Jun 21. Pathol Oncol Res. 2012. PMID: 22718338
-
Immunotherapy for KSHV-associated diseases.Curr Opin Virol. 2022 Aug;55:101249. doi: 10.1016/j.coviro.2022.101249. Epub 2022 Jul 5. Curr Opin Virol. 2022. PMID: 35803203 Free PMC article. Review.
-
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.Cell Mol Life Sci. 2012 Oct;69(20):3395-418. doi: 10.1007/s00018-012-0989-2. Epub 2012 Apr 24. Cell Mol Life Sci. 2012. PMID: 22527721 Free PMC article. Review.
References
-
- Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. - PubMed
-
- Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–1869. - PubMed
-
- Centers for Disease Control. Kaposi’s sarcoma and pneumocystis pneumonia among homosexual men: New York City and California. MMWR. 1981;30:305–308. - PubMed
-
- Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–1431. - PubMed
-
- Siegal FP, Lopez C, Hammer GS, Brown AE, Kornfeld SJ, Gold J, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439–1444. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical